CN104136036A - Hiv杀微生物剂及其应用 - Google Patents

Hiv杀微生物剂及其应用 Download PDF

Info

Publication number
CN104136036A
CN104136036A CN201380008507.5A CN201380008507A CN104136036A CN 104136036 A CN104136036 A CN 104136036A CN 201380008507 A CN201380008507 A CN 201380008507A CN 104136036 A CN104136036 A CN 104136036A
Authority
CN
China
Prior art keywords
hiv
microbicide
sifuvirtide
sft
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380008507.5A
Other languages
English (en)
Inventor
张晓燕
李亮助
徐建青
贲银银
姜世勃
陈昕
赵亚婷
鞠丹
董天皞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinjiang Hengyuan Technology Development Co ltd
Fudan University
Tianjin Fusogen Pharmaceuticals Inc
Original Assignee
Jinjiang Hengyuan Technology Development Co ltd
Tianjin Fusogen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinjiang Hengyuan Technology Development Co ltd, Tianjin Fusogen Pharmaceuticals Inc filed Critical Jinjiang Hengyuan Technology Development Co ltd
Priority to CN201380008507.5A priority Critical patent/CN104136036A/zh
Publication of CN104136036A publication Critical patent/CN104136036A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明公开了一种HIV杀微生物剂及其用途，该杀微生物剂含有西夫韦肽和另外或治疗艾滋病的药物，如逆转录酶抑制剂。

Description

PCT国内申请，说明书已公开。

Claims (1)

  1. PCT国内申请，权利要求书已公开。
CN201380008507.5A 2012-02-14 2013-01-31 Hiv杀微生物剂及其应用 Pending CN104136036A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201380008507.5A CN104136036A (zh) 2012-02-14 2013-01-31 Hiv杀微生物剂及其应用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201210033221.X 2012-02-14
CN201210033221XA CN103239712A (zh) 2012-02-14 2012-02-14 Hiv杀微生物剂及其应用
PCT/CN2013/071201 WO2013120414A1 (zh) 2012-02-14 2013-01-31 Hiv杀微生物剂及其应用
CN201380008507.5A CN104136036A (zh) 2012-02-14 2013-01-31 Hiv杀微生物剂及其应用

Publications (1)

Publication Number Publication Date
CN104136036A true CN104136036A (zh) 2014-11-05

Family

ID=48919815

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201210033221XA Pending CN103239712A (zh) 2012-02-14 2012-02-14 Hiv杀微生物剂及其应用
CN201380008507.5A Pending CN104136036A (zh) 2012-02-14 2013-01-31 Hiv杀微生物剂及其应用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201210033221XA Pending CN103239712A (zh) 2012-02-14 2012-02-14 Hiv杀微生物剂及其应用

Country Status (3)

Country Link
CN (2) CN103239712A (zh)
HK (1) HK1201746A1 (zh)
WO (1) WO2013120414A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106267234B (zh) * 2015-06-26 2020-04-10 上海市计划生育科学研究所 含有非核苷类逆转录酶抑制剂的阴道环及其制备方法
JP6761559B2 (ja) * 2018-08-23 2020-09-23 朋剛 松田 ヒト免疫不全ウイルスの感染予防のための組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100021427A1 (en) * 2008-05-29 2010-01-28 Tianjin Fusogen Pharmaceuticals, Inc. Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV
CN102247590A (zh) * 2010-05-18 2011-11-23 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药物组合及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101088557A (zh) * 2006-06-12 2007-12-19 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药用组合物及其应用
CN101810583B (zh) * 2010-04-09 2013-09-11 佟丽 Hiv融合抑制剂缓释微球
AU2011248279A1 (en) * 2010-05-03 2012-11-01 New York Blood Center, Inc. Bifunctional molecules for inactivating HIV and blocking HIV

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100021427A1 (en) * 2008-05-29 2010-01-28 Tianjin Fusogen Pharmaceuticals, Inc. Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV
CN102247590A (zh) * 2010-05-18 2011-11-23 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药物组合及其应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
史卫国等: "HIV-1 融合抑制剂研究现状以及发展趋势", 《药学学报》 *

Also Published As

Publication number Publication date
CN103239712A (zh) 2013-08-14
HK1201746A1 (zh) 2015-09-11
WO2013120414A1 (zh) 2013-08-22

Similar Documents

Publication Publication Date Title
M Tebit et al. Mucosal transmission of human immunodeficiency virus
Bernstein et al. Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes
Shattock et al. Microbicides: topical prevention against HIV
Howett et al. A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses
Miller et al. Target cells in vaginal HIV transmission
Cutler et al. Vaginal microbicides and the prevention of HIV transmission
Shen et al. Early HIV‐1 target cells in human vaginal and ectocervical mucosa
Ariën et al. HIV sexual transmission and microbicides
Whaley et al. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines
Sagar HIV-1 transmission biology: selection and characteristics of infecting viruses
EP1030547B1 (en) Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
Neurath et al. Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides
EA011298B1 (ru) Применение бактерицидных пиримидинов для профилактики передачи вич половым путём и фармацевтические композиции на их основе
Barreto‐de‐Souza et al. HIV‐1 vaginal transmission: cell‐free or cell‐associated virus?
Zussman et al. Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781
Fernández-Romero et al. Preclinical assessments of vaginal microbicide candidate safety and efficacy
CN1597008A (zh) 含有泊洛沙姆和其它杀微生物剂的局部制剂，以及施用器
Li et al. Efficacy, stability, and biosafety of sifuvirtide gel as a microbicide candidate against HIV-1
CA2800670C (en) Topical antiviral formulations
Fraietta et al. Phosphorothioate 2′ deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1
Gupta Microbicides: a new hope for HIV prevention
Roy et al. Thermoreversible gel formulations containing sodium lauryl sulfate or n-lauroylsarcosine as potential topical microbicides against sexually transmitted diseases
Stolte-Leeb et al. Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques
CN104136036A (zh) Hiv杀微生物剂及其应用
Naswa et al. Microbicides and HIV: A Review and an update

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1201746

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141105

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1201746

Country of ref document: HK